Neuronetics
Latest round
- Series G
Last raised
- Jun 2017
Total raised
- $153M
Investors
- 15
About Neuronetics
Founded in 2001 and based in Pennsylvania, US, Neuronetics, Inc. develops and manufactures NeuroStar TMS, a non-invasive therapeutic device for the healthcare industry. In July 2018, Neuronetics, Inc. started trading on the Nasdaq global select market under the ticker symbol STIM. The company's research and development team offer NeuroStar TMS therapy based upon neuromodulation technology for patients with a major depressive disorder and not benefited from prior antidepressant treatment. The medical device produces MRI-strength magnetic field pulses to stimulate underactive brain areas that result in non-invasive and symptom relief for chronic psychiatric and neurological disorders. The company generates revenue by commercializing products that improve patients' quality of life who suffer from psychiatric disorders.7 million for FY 2019. The company plans to continue the clinical trials and use the outcomes registry data to lay the groundwork for future advancements and treatment protocols.
Who invested in Neuronetics
15 investors across 7 rounds
See all investors in Neuronetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series G
Jun 1, 2017
Amount
$15M
Investors
Series F
May 6, 2015
Amount
$34M
Investors
Series E
May 13, 2011
Amount
$30M
Investors
Series D
Aug 21, 2009
Amount
$30M
Investors
Series C
Aug 14, 2006
Amount
$35M
Investors
Series B
Mar 31, 2005
Amount
$8.5M
Investors
Seed
Aug 1, 2001
Amount
Undisclosed
Investors
Questions about Neuronetics
Who invested in Neuronetics?
Neuronetics has 15 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neuronetics raised?
Neuronetics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Neuronetics last raise money?
Neuronetics's most recent round on record is a Series G, in Jun 2017.
What does Neuronetics do?
Founded in 2001 and based in Pennsylvania, US, Neuronetics, Inc.
Where is Neuronetics headquartered?
Neuronetics is headquartered in Malvern, US.
Which VCs invest in companies like Neuronetics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Neuronetics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series G
Raising like Neuronetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.